Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$17.54
Market cap
$2.62B
P/E Ratio
38.13
Dividend/share
$1
EPS
$0.46
Enterprise value
$6.19B
The Chemours Company is a global leader in Titanium Technologies, Fluoroproducts, and Chemical Solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise
Highlights
The net income has soared by 122% YoY but it has contracted by 36% from the previous quarter
The EPS has soared by 122% year-on-year but it has declined by 36% since the previous quarter
The quick ratio has contracted by 13% YoY and by 6% from the previous quarter
Chemours's equity has decreased by 13% YoY and by 9% from the previous quarter
Key stats
What are the main financial stats of CC
Market
Valuations
Earnings
Shares outstanding
149.41M
Market cap
$2.62B
Enterprise value
$6.19B
Price to earnings (P/E)
38.13
Price to book (P/B)
3.99
Price to sales (P/S)
0.46
EV/EBIT
20.71
EV/EBITDA
10.39
EV/Sales
1.08
Revenue
$5.75B
Gross profit
$1.13B
Net income
$69M
EBIT
$299M
EBITDA
$596M
Free cash flow
-$673M
Per share
Balance sheet
Liquidity
EPS
$0.46
EPS diluted
$0.44
Free cash flow per share
-$4.51
Book value per share
$4.4
Revenue per share
$38.52
TBVPS
$49.67
Total assets
$7.46B
Total liabilities
$6.8B
Debt
$4.24B
Equity
$657M
Working capital
$1.3B
Debt to equity
6.45
Current ratio
1.73
Quick ratio
0.91
Net debt/EBITDA
5.99
Margins
Efficiency
Dividend
EBITDA margin
10.4%
Gross margin
19.6%
Net margin
1.2%
Operating margin
4.4%
Return on assets
0.9%
Return on equity
9.6%
Return on invested capital
3.4%
Return on capital employed
5.3%
Return on sales
5.2%
Dividend yield
5.7%
DPS
$1
Payout ratio
217.4%
CC stock price
How has the Chemours stock price performed over time
Intraday
0%
1 week
-3.68%
1 month
-18.53%
1 year
-44.83%
YTD
-44.39%
QTD
-13.68%
Financial performance
How have Chemours's revenue and profit performed over time
Revenue
$5.75B
Gross profit
$1.13B
Operating income
$255M
Net income
$69M
Gross margin
19.6%
Net margin
1.2%
Chemours's net margin has soared by 123% YoY but it has decreased by 37% from the previous quarter
The net income has soared by 122% YoY but it has contracted by 36% from the previous quarter
The operating income has increased by 36% QoQ
The operating margin rose by 33% since the previous quarter
Growth
What is Chemours's growth rate over time
Valuation
What is Chemours stock price valuation
P/E
38.13
P/B
3.99
P/S
0.46
EV/EBIT
20.71
EV/EBITDA
10.39
EV/Sales
1.08
The EPS has soared by 122% year-on-year but it has declined by 36% since the previous quarter
The P/B is 23% lower than the last 4 quarters average of 5.2 and 15% lower than the 5-year quarterly average of 4.7
Chemours's equity has decreased by 13% YoY and by 9% from the previous quarter
CC's P/S is 34% lower than its 5-year quarterly average of 0.7 and 23% lower than its last 4 quarters average of 0.6
The company's revenue fell by 4.2% YoY
Efficiency
How efficient is Chemours business performance
The ROE has soared by 130% YoY but it has contracted by 34% from the previous quarter
CC's ROA has soared by 122% YoY but it is down by 36% QoQ
The company's return on invested capital fell by 11% QoQ
The ROS has declined by 9% since the previous quarter
Dividends
What is CC's dividend history
DPS
$1
Dividend yield
5.7%
Payout ratio
217.4%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Chemours financials performed over time
The company's total assets is 10% higher than its total liabilities
The quick ratio has contracted by 13% YoY and by 6% from the previous quarter
The current ratio is down by 8% QoQ but it is up by 3% YoY
Chemours's debt to equity has increased by 17% YoY and by 11% from the previous quarter
Chemours's equity has decreased by 13% YoY and by 9% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.